Department of Medicine, University of Udine, Italy.
Department of Anesthesia and Intensive Care, University Hospital of Udine, Italy, Udine, Italy.
Ultraschall Med. 2022 Oct;43(5):464-472. doi: 10.1055/a-1634-4710. Epub 2021 Nov 3.
The goal of this survey was to describe the use and diffusion of lung ultrasound (LUS), the level of training received before and during the COVID-19 pandemic, and the clinical impact LUS has had on COVID-19 cases in intensive care units (ICU) from February 2020 to May 2020.
The Italian Lung Ultrasound Survey (ITALUS) was a nationwide online survey proposed to Italian anesthesiologists and intensive care physicians carried out after the first wave of the COVID-19 pandemic. It consisted of 27 questions, both quantitative and qualitative.
807 responded to the survey. The median previous LUS experience was 3 years (IQR 1.0-6.0). 473 (60.9 %) reported having attended at least one training course on LUS before the COVID-19 pandemic. 519 (73.9 %) reported knowing how to use the LUS score. 404 (52 %) reported being able to use LUS without any supervision. 479 (68.2 %) said that LUS influenced their clinical decision-making, mostly with respect to patient monitoring. During the pandemic, the median of patients daily evaluated with LUS increased 3-fold (p < 0.001), daily use of general LUS increased from 10.4 % to 28.9 % (p < 0.001), and the daily use of LUS score in particular increased from 1.6 % to 9.0 % (p < 0.001).
This survey showed that LUS was already extensively used during the first wave of the COVID-19 pandemic by anesthesiologists and intensive care physicians in Italy, and then its adoption increased further. Residency programs are already progressively implementing LUS teaching. However, 76.7 % of the sample did not undertake any LUS certification.
本研究旨在描述肺超声(LUS)的使用和普及情况、在 COVID-19 大流行前后接受培训的程度,以及 LUS 对 2020 年 2 月至 5 月 ICU 中 COVID-19 病例的临床影响。
意大利肺超声调查(ITALUS)是一项在 COVID-19 大流行第一波过后向意大利麻醉师和重症监护医师提出的全国性在线调查。它包含 27 个问题,包括定量和定性问题。
807 名受访者回应了这项调查。此前 LUS 经验的中位数为 3 年(IQR 1.0-6.0)。473 名(60.9%)报告在 COVID-19 大流行前至少参加过一次 LUS 培训课程。519 名(73.9%)报告知道如何使用 LUS 评分。404 名(52%)报告能够在没有任何监督的情况下使用 LUS。479 名(68.2%)表示 LUS 影响了他们的临床决策,主要是在患者监测方面。在大流行期间,每天使用 LUS 评估的患者中位数增加了 3 倍(p<0.001),日常使用通用 LUS 的比例从 10.4%增加到 28.9%(p<0.001),特别是 LUS 评分的日常使用比例从 1.6%增加到 9.0%(p<0.001)。
这项调查表明,在 COVID-19 大流行的第一波期间,意大利的麻醉师和重症监护医师已经广泛使用 LUS,随后其应用进一步增加。住院医师培训计划已经在逐步实施 LUS 教学。然而,样本中的 76.7%没有进行任何 LUS 认证。